Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya

INTRODUCTION: Globally, many young women face the overlapping burden of HIV infection and unintended pregnancy. Protection against both may benefit from safe and effective multipurpose prevention technologies. METHODS: Healthy women ages 18–34 years, not pregnant, seronegative for HIV and hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mugo, Nelly R., Mudhune, Victor, Heffron, Renee, Thomas, Katherine K., McLellan-Lemal, Eleanor, Njoroge, Betty, Peacock, Sue, O’Connor, Siobhán M., Nyagol, Beatrice, Ouma, Eunice, Ridzon, Renee, Wiener, Jeffrey, Isoherranen, Nina, Erikson, David W., Ouattara, Louise A., Yousefieh, Nazita, Jacot, Terry A., Haaland, Richard E., Morrison, Susan A., Haugen, Harald S., Thurman, Andrea R., Allen, Shannon A., Baeten, Jared M., Samandari, Taraz, Doncel, Gustavo F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Reproductive Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293630/
https://www.ncbi.nlm.nih.gov/pubmed/37383290
http://dx.doi.org/10.3389/frph.2023.1118030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293630/
https://www.ncbi.nlm.nih.gov/pubmed/37383290
http://dx.doi.org/10.3389/frph.2023.1118030

Ejemplares similares